MUC16 and ovarian carcinoma: Long-term monitoring of ovarian cancer patients using digital cytometry enhanced with gold nanoparticles revealed that elevated MUC16 levels on peripheral blood mononuclear cells (PBMCs) surface predict tumor relapse and metastasis risk, with MUC16 levels in ovarian cancer patients’ PBMCs higher than in healthy controls (82).